| Literature DB >> 35494948 |
Ahmad Bashir1, Sahar K Zuberi2, Rimsha Khan1, M Hammad Ather3.
Abstract
Background In this study, we aimed to translate and validate the 19-item version of the Bristol Female Lower Urinary Tract Symptoms (Bristol FLUTS) Questionnaire in Urdu among women experiencing urinary incontinence at a tertiary care hospital in Karachi, Pakistan. Methodology A cross-sectional validation study was conducted in the urology clinic at Aga Khan University Hospital, Karachi, Pakistan, between April and September 2021. After forward and backward translation of the Bristol FLUTS questionnaire, content validation was done by six experts, followed by the administration of the questionnaire to 10 respondents in the pilot phase of the study. In total, 207 participants were approached to fill the final version of the translated questionnaire. Overall, 188 respondents filled out the questionnaire, including 94 women with urinary incontinence and 94 women from the community to test construct validity. Finally, 30 women with urinary incontinence were asked to fill the form again two weeks later to determine test-retest reliability. Cronbach's alpha was employed to assess the internal consistency of the questionnaire. Results The questionnaire displayed good content validity for reliability (content validity index: 0.84) and clarity (0.89). The scores reported by cases were significantly higher than the controls in all but the sexual function domain, suggesting good construct validity. Cronbach's alpha of 0.81 signified good internal consistency, and a Pearson's coefficient of 0.993 (p < 0.001) comparing responses at baseline and after two weeks indicated good test-retest reliability. Conclusions The Urdu translation of the Bristol FLUTS is a valid and reliable questionnaire that can be used in the clinical setting.Entities:
Keywords: questionnaire; urdu; urinary incontinence; validation; women’s health
Year: 2022 PMID: 35494948 PMCID: PMC9044913 DOI: 10.7759/cureus.23564
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Scores of individual items rated by experts on the basis of their relevance and clarity.
CVI = content validity index
| CVI score (0-1) | Relevance (n = 19); n (%) | Clarity (n = 19); n (%) |
| 1 | 8 (42.1) | 12 (63.1) |
| 0.83 | 6 (31.6) | 2 (10.5) |
| 0.67 | 3 (15.8) | 4 (21.1) |
| 0.5 | 2 (10.5) | 1 (5.3) |
Comparison of scores of individual items of the questionnaire in women with urinary incontinence and those without any symptoms.
SE = standard error; CI = confidence interval, * = significant (p < 0.05)
| Case (n = 94); mean ± SE | Control (n = 94); mean ± SE | P-value (CI) | |
| Filling | |||
| F1 | 3.20 ± 0.14 | 1.67 ± 0.09 | <0.001 (1.20,1.86)* |
| F2 | 3.12 ± 0.16 | 1.11 ± 0.03 | <0.001 (1.67,2.33)* |
| F3 | 2.63 ± 0.10 | 2.30 ± 0.07 | 0.007 (0.09,0.57)* |
| F4 | 2.16 ± 0.14 | 1.10 ± 0.03 | <0.001 (0.78,1.35)* |
| Voiding | |||
| V1 | 1.77 ± 0.11 | 1.00 ± 0 | <0.001 (0.64,1.19)* |
| V2 | 1.91 ± 0.14 | 1.00 ± 0 | <0.001 (0.54,0.99)* |
| V3 | 2.41 ± 0.16 | 1.01 ± 0.01 | <0.001 (1.08,1.73)* |
| Incontinence | |||
| I1 | 2.32 ± 0.14 | 1.05 ± 0.02 | <0.001 (0.99,1.54)* |
| I2 | 2.41 ± 0.13 | 1.11 ± 0.03 | <0.001 (1.04,1.58)* |
| I3 | 1.21 ± 0.07 | 1.00 ± 0 | 0.005 (0.07,0.36)* |
| I4 | 2.53 ± 0.17 | 1.47 ± 0.08 | <0.001 (0.70,1.43)* |
| I5 | 1.29 ± 0.09 | 1.00 ± 0 | 0.001 (0.11,0.46)* |
| Sexual function | |||
| S1 | 1.03 ± 0.02 | 1.05 ± 0.23 | 0.473 (-0.08,0.04) |
| S2 | 1.19 ± 0.07 | 1.05 ± 0.23 | 0.067 (-0.01,0.29) |
| Quality of life | |||
| Qol 1 | 2.94 ± 0.13 | 1.33 ± 0.07 | <0.001 (1.32,1.89)* |
| Qol 2 | 2.37 ± 0.14 | 1.05 ± 0.02 | <0.001 (1.04,1.60)* |
| Qol 3 | 3.60 ± 0.12 | 1.27 ± 0.05 | <0.001 (2.07,2.58)* |
| Qol 4 | 2.99 ± 0.11 | 1.19 ± 0.04 | <0.001 (1.56,2.03)* |
| Qol 5 | 3.45 ± 0.08 | 1.33 ± 0.07 | <0.001 (1.92,2.32)* |
Correlation between the severity of symptoms at baseline and two weeks later.
| Pearson’s r | P-value | |
| Filling | 0.987 | <0.001 |
| Voiding | 0.995 | <0.001 |
| Incontinence | 0.986 | <0.001 |
| Sexual function | 1.000 | <0.001 |
| Quality of life | 0.978 | <0.001 |